| Protective role of magic fruit and honey bee against human hepatocarcinogenesis MM Selim Cancer Summit, 2020 | 3 | 2020 |
| The possibility of cervical cancer & endometrial cancer paradigm for surgical management B Dennis J Can Clinical Res 5 (6), 130, 2022 | | 2022 |
| Neoadjuvant therapy pancreatic cancer& Breast Cancer meta-analysis of randomized controlled trials M Ferraro J Can Clinical Res 5 (4), 120, 2022 | | 2022 |
| Review on defensive roles of thymoquinone nanobiosensoring prospective in opposition to cancer. AM Sikkander Journal of cancer clinical research 4 (1), 2021 | | 2021 |
| A small research article on: A comment on the mechanism of the life activity AY Rojeab Journal of cancer clinical research 3 (2), 2020 | | 2020 |
| The pattern of recurrence and survival after treatment failure in patients with rectal cancer treated with combined modality therapy JLS Ahmed Journal of cancer clinical research 3 (1), 2020 | | 2020 |
| Anti-inflammatory drug resistance in breast and colon cancer stem cells: Preclinical leads N Telang Journal of cancer clinical research 2 (2), 2019 | | 2019 |
| Artificial intelligence in fighting lung cancer for antivirus surfaces. R Walter | | |
| Molecular signatures exposure of childhood retinoblastoma tumors J Saskia J Can Clinical Res. 2022; 5 (4) 117, 0 | | |
| Pathologic correlation of tracheobronchial tumors B Liyan J Can Clinical Res. 2022; 5 (6) 129, 1-3, 0 | | |
| Validation of a novel apoptosis chemotherapeutic drugs effect of osteosarcoma metastasis Z Liu J Can Clinical Res. 2022; 5 (4): 118 1 J Can Clinical Res 2022 Volume 5 …, 0 | | |
| Advances in diagnosis and treatment of breast cancer recurrence M Manzoor, N Rastogi, S Rashid J Can Clinical Res. 2021; 5 (2) 110, 0 | | |
| Management of Oesophageal Carcinoma P Singh J Can Clinical Res. 2023; 6 (1): 131 1 J Can Clinical Res 2023 Volume 6 …, 0 | | |
| Mutations of melanoma on Cholecystokinin receptor antagonist by inducing apoptosis of tumor cells R Andrew J Can Clinical Res. 2022; 5 (4): 119 1 J Can Clinical Res 2022 Volume 5 …, 0 | | |
| Evaluation of surgical risk in patients with liver cancer MA Sikkander, K Yasmeen J Can Clinical Res. 2022; 5 (3): 115 1 J Can Clinical Res 2022 Volume 5 …, 0 | | |
| Medullary thyroid cancer Guidelinesa A Arnoldo J Can Clinical Res. 2023; 6 (1) 133, 0 | | |
| Analysis radiotherapy for prostate cancer and toxicities of bladder cancer J Evelyn J Can Clinical Res. 2022; 5 (6) 126, 0 | | |
| A pilot study of Barriers to interventional radiology for hepatocellular carcinoma S Osinski J Can Clinical Res. 2022; 5 (4): 116 1 J Can Clinical Res 2022 Volume 5 …, 0 | | |
| Advances in diagnosis and treatment of breast cancer recurrence S Basu, M Manzoor, N Rastogi J Can Clinical Res. 2022; 5 (2): 110 1 J Can Clinical Res 2022 Volume 5 …, 0 | | |
| Perceptions and nutritional management for esophageal cancer & pancreatic cancer Y Hiraoka J Can Clinical Res. 2022; 5 (2) 109, 1-8, 0 | | |
Dr A Mohamed SikkanderAssociate Professor & Head,Department of chemistry,Velammal Engineering CollegeVerified email at velammal.edu.in
